Oscar Briz

10PUBLICATIONS
39CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Cell development, proliferation and deathHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jul 11, 2026
A transcriptomic five-gene signature for sorafenib response prediction in hepatocellular carcinoma: clinical promise and limitations.

|Jul 30, 2025
Drug-Resistant Cholangiocarcinoma Cell Lines for Therapeutic Evaluation of Novel Drugs.

Kevin Delgado-Calvo, Elisa Lozano, Oscar Briz

|May 06, 2024
Strategies to enhance the response of liver cancer to pharmacological treatments.

Jose J G Marin, Rocio I R Macias, Maitane Asensio

|Jun 28, 2023
Role of Intracellular Drug Disposition in the Response of Acute Myeloid Leukemia to Cytarabine and Idarubicin Induction Chemotherapy.

Gabriela Rodríguez-Macías, Oscar Briz, Candela Cives-Losada

|Dec 23, 2022
Impact of Liver Inflammation on Bile Acid Side Chain Shortening and Amidation.

Marta Alonso-Peña, Ricardo Espinosa-Escudero, Heike M Hermanns

|Jul 27, 2022
Expression of Chemoresistance-Associated ABC Proteins in Hepatobiliary, Pancreatic and Gastrointestinal Cancers.

Jose J G Marin, Maria J Monte, Rocio I R Macias

Pageof 2

Frequent Collaborators

10 joint publications

Jose J G Marin

7 joint publications

Rocio I R Macias

5 joint publications

Elisa Herraez

4 joint publications

Maria J Monte